<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:52:53Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10611992" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10611992</identifier>
        <datestamp>2023-10-29</datestamp>
        <setSpec>jamasd</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id>
              <journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id>
              <journal-title-group>
                <journal-title>JAMA Network Open</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2574-3805</issn>
              <publisher>
                <publisher-name>American Medical Association</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10611992</article-id>
              <article-id pub-id-type="pmcid">PMC10611992</article-id>
              <article-id pub-id-type="pmc-uid">10611992</article-id>
              <article-id pub-id-type="pmid">37889487</article-id>
              <article-id pub-id-type="pmid">37889487</article-id>
              <article-id pub-id-type="doi">10.1001/jamanetworkopen.2023.39337</article-id>
              <article-id pub-id-type="publisher-id">zoi231147</article-id>
              <article-categories>
                <subj-group subj-group-type="category" specific-use="electronic">
                  <subject>Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Investigation</subject>
                </subj-group>
                <subj-group subj-group-type="online-only">
                  <subject>Online Only</subject>
                </subj-group>
                <subj-group subj-group-type="subject-area">
                  <subject>Nutrition, Obesity, and Exercise</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes</article-title>
                <subtitle>A Randomized Clinical Trial</subtitle>
                <alt-title alt-title-type="headline">Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes</alt-title>
                <alt-title alt-title-type="running-head">Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pavlou</surname>
                    <given-names>Vasiliki</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cienfuegos</surname>
                    <given-names>Sofia</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lin</surname>
                    <given-names>Shuhao</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ezpeleta</surname>
                    <given-names>Mark</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ready</surname>
                    <given-names>Kathleen</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Corapi</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wu</surname>
                    <given-names>Jackie</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lopez</surname>
                    <given-names>Jason</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gabel</surname>
                    <given-names>Kelsey</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tussing-Humphreys</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <degrees>RD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi231147aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Oddo</surname>
                    <given-names>Vanessa M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Alexandria</surname>
                    <given-names>Shaina J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi231147aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sanchez</surname>
                    <given-names>Julienne</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi231147aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Unterman</surname>
                    <given-names>Terry</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi231147aff4" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                  <xref rid="zoi231147aff5" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chow</surname>
                    <given-names>Lisa S.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <degrees>MS</degrees>
                  <xref rid="zoi231147aff6" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vidmar</surname>
                    <given-names>Alaina P.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="zoi231147aff7" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Varady</surname>
                    <given-names>Krista A.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="zoi231147aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="zoi231147aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="zoi231147aff1"><label>1</label>Department of Kinesiology and Nutrition, University of Illinois Chicago</aff>
              <aff id="zoi231147aff2"><label>2</label>University of Illinois Cancer Center, University of Illinois Chicago</aff>
              <aff id="zoi231147aff3"><label>3</label>Department of Preventative Medicine (Biostatistics), Northwestern University, Chicago, Illinois</aff>
              <aff id="zoi231147aff4"><label>4</label>College of Medicine (Endocrinology), University of Illinois Chicago</aff>
              <aff id="zoi231147aff5"><label>5</label>Department of Endocrinology, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois</aff>
              <aff id="zoi231147aff6"><label>6</label>Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, University of Minnesota, Minneapolis</aff>
              <aff id="zoi231147aff7"><label>7</label>Center for Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Children’s Hospital Los Angeles and Keck School of Medicine of the University of Southern California, Los Angeles</aff>
              <author-notes>
                <title>Article Information</title>
                <p><bold>Accepted for Publication:</bold> September 9, 2023.</p>
                <p content-type="published-online"><bold>Published:</bold> October 27, 2023. <?xpp bx;1?>doi:<uri content-type="doi">10.1001/jamanetworkopen.2023.39337</uri></p>
                <p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-nc-nd-license-permissions" ext-link-type="uri">CC-BY-NC-ND License</ext-link>. © 2023 Pavlou V et al. <italic>JAMA Network Open</italic>.</p>
                <corresp id="zoi231147cor1"><bold>Corresponding Author:</bold> Krista A. Varady, PhD, Department of Kinesiology and Nutrition, University of Illinois Chicago, 1919 W Taylor St, Chicago, IL 60612 (<email xlink:href="varady@uic.edu">varady@uic.edu</email>).</corresp>
                <p content-type="author-contributions"><bold>Author Contributions:</bold> Dr Varady had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
                <p><italic>Concept and design:</italic> Pavlou, Cienfuegos, Lin, Gabel, Unterman, Varady.</p>
                <p><italic>Acquisition, analysis, or interpretation of data:</italic> Pavlou, Cienfuegos, Ezpeleta, Ready, Corapi, Wu, Lopez, Tussing-Humphreys, Oddo, Alexandria, Sanchez, Unterman, Chow, Vidmar, Varady.</p>
                <p><italic>Drafting of the manuscript:</italic> Pavlou, Wu, Tussing-Humphreys, Vidmar, Varady.</p>
                <p><italic>Critical review of the manuscript for important intellectual content:</italic> Pavlou, Cienfuegos, Lin, Ezpeleta, Ready, Corapi, Lopez, Gabel, Tussing-Humphreys, Oddo, Alexandria, Sanchez, Unterman, Chow, Vidmar, Varady.</p>
                <p><italic>Statistical analysis:</italic> Cienfuegos, Oddo, Alexandria, Vidmar.</p>
                <p><italic>Obtained funding:</italic> Varady.</p>
                <p><italic>Administrative, technical, or material support:</italic> Pavlou, Cienfuegos, Lin, Ready, Lopez, Sanchez, Unterman, Vidmar.</p>
                <p><italic>Supervision:</italic> Pavlou, Cienfuegos, Lin, Gabel, Varady.</p>
                <p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Ms Ready reported being a member of the Certified Diabetes Care and Education Specialist for the Academy of Nutrition and Dietetics and being employed as a clinician at Ascension Medical Group Weight Loss Solutions and Diabetes Education outside the submitted work. Dr Chow reported receiving nonfinancial support from DexCom Inc outside the submitted work. Dr Vidmar reported receiving consulting fees from Rhythm Pharmaceuticals Inc, Hippo Technologies Inc, and Guidepoint Inc and grant funding from DexCom Inc, outside the submitted work. Dr Varady reported receiving grant funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) during the conduct of the study; receiving personal fees from the NIH for serving on the data and safety monitoring boards for the Health, Aging and Later-Life Outcomes and Dial Health studies; receiving author fees from Pan MacMillan for <italic>The Fastest Diet</italic>; and serving as the associate editor for nutrition reviews from Elsevier outside the submitted work. No other disclosures were reported.</p>
                <p content-type="funding-statement"><bold>Funding/Support:</bold> This study was supported by the Department of Kinesiology and Nutrition, University of Illinois Chicago, and by grants R01DK128180 and T32DK128782 from the NIDDK of the NIH (Dr Varady).</p>
                <p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p>
                <p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p>
              </author-notes>
              <pub-date pub-type="epub" iso-8601-date="2023-10-27T10:00">
                <day>27</day>
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>27</day>
                <month>10</month>
                <year>2023</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>6</volume>
              <issue>10</issue>
              <elocation-id>e2339337</elocation-id>
              <history>
                <date date-type="received">
                  <day>6</day>
                  <month>8</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>9</day>
                  <month>9</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2023 Pavlou V et al. <italic>JAMA Network Open</italic>.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the CC-BY-NC-ND License.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2339337.pdf">jamanetwopen-e2339337.pdf</self-uri>
              <self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.39337"/>
              <abstract abstract-type="key-points">
                <title>Key Points</title>
                <sec id="ab-zoi231147-1">
                  <title>Question</title>
                  <p>Is time-restricted eating (TRE) without calorie counting more effective for weight loss and lowering of hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) levels compared with daily calorie restriction (CR) in adults with type 2 diabetes (T2D)?</p>
                </sec>
                <sec id="ab-zoi231147-2">
                  <title>Findings</title>
                  <p>In a 6-month randomized clinical trial involving 75 adults with T2D, TRE was more effective for weight loss (−3.6%) than CR (−1.8%) compared with controls. However, changes in HbA<sub>1c</sub> levels did not differ between the TRE (−0.91%) and CR (−0.94%) groups compared with controls.</p>
                </sec>
                <sec id="ab-zoi231147-3">
                  <title>Meaning</title>
                  <p>These findings suggest that time-restricted eating may be an effective alternative strategy to CR for lowering body weight and HbA<sub>1c</sub> levels in T2D.</p>
                </sec>
              </abstract>
              <abstract abstract-type="teaser" specific-use="electronic">
                <p>This randomized clinical trial compares the effects of 8-hour time-restricted eating with daily calorie restriction and a control condition on body weight and glycemic control in adults with type 2 diabetes and obesity.</p>
              </abstract>
              <abstract>
                <sec id="ab-zoi231147-4">
                  <title>Importance</title>
                  <p>Time-restricted eating (TRE) has become increasingly popular, yet longer-term randomized clinical trials have not evaluated its efficacy and safety in patients with type 2 diabetes (T2D).</p>
                </sec>
                <sec id="ab-zoi231147-5">
                  <title>Objective</title>
                  <p>To determine whether TRE is more effective for weight reduction and glycemic control than daily calorie restriction (CR) or a control condition in adults with T2D.</p>
                </sec>
                <sec id="ab-zoi231147-6">
                  <title>Design, Setting, and Participants</title>
                  <p>This 6-month, parallel-group, randomized clinical trial was performed between January 25, 2022, and April 1, 2023, at the University of Illinois Chicago. Participants were aged 18 to 80 years with obesity and T2D. Data analysis was based on intention to treat.</p>
                </sec>
                <sec id="ab-zoi231147-7">
                  <title>Interventions</title>
                  <p>Participants were randomized to 1 of 3 groups: 8-hour TRE (eating 12 to 8 <sc>pm</sc> only, without calorie counting), CR (25% energy restriction daily), or control.</p>
                </sec>
                <sec id="ab-zoi231147-8">
                  <title>Main Outcomes and Measures</title>
                  <p>The primary outcome measure was change in body weight by month 6. Secondary outcomes included changes in hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) levels and metabolic risk factors.</p>
                </sec>
                <sec id="ab-zoi231147-9">
                  <title>Results</title>
                  <p>Seventy-five participants were enrolled with a mean (SD) age of 55 (12) years. The mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) was 39 (7) and the mean (SD) HbA<sub>1c</sub> level was 8.1% (1.6%). A total of 53 participants (71%) were women. One participant (1%) was Asian, 30 (40%) were Hispanic White, 40 (53%) were non-Hispanic Black, and 4 (5%) were non-Hispanic White. Participants in the TRE group were adherent with their eating window on a mean (SD) of 6.1 (0.8) days per week, and 17 (68%) in the CR group were adherent with their prescribed calorie goals over 6 months. The mean (SD) reduction in energy intake was −313 (509) kcal/d for TRE, −197 (426) kcal/d for CR, and −16 (439) kcal/d for controls. By month 6, body weight decreased significantly in the TRE group (−3.56% [95% CI, −5.92% to −1.20%]; <italic>P</italic> = .004) but not the CR group (−1.78% [95% CI, −3.67% to 0.11%]; <italic>P</italic> = .06), relative to controls. Levels of HbA<sub>1c</sub> decreased in the TRE (−0.91% [95% CI, −1.61% to −0.20%]) and CR (−0.94% [95% CI, −1.59% to −0.30%]) groups, relative to controls, with no differences between the TRE and CR groups. Time in euglycemic range, medication effect score, blood pressure, and plasma lipid levels did not differ among groups. No serious adverse events were reported.</p>
                </sec>
                <sec id="ab-zoi231147-10">
                  <title>Conclusions and relevance</title>
                  <p>This randomized clinical trial found that a TRE diet strategy without calorie counting was effective for weight loss and lowering of HbA<sub>1c</sub> levels compared with daily calorie counting in a sample of adults with T2D. These findings will need to be confirmed by larger RCTs with longer follow-up.</p>
                </sec>
                <sec id="ab-zoi231147-11">
                  <title>Trial Registration</title>
                  <p>ClinicalTrials.gov Identifier: <ext-link xlink:href="https://classic.clinicaltrials.gov/ct2/show/NCT05225337" ext-link-type="uri">NCT05225337</ext-link></p>
                </sec>
              </abstract>
            </article-meta>
          </front>
          <body>
            <sec id="H1-1-ZOI231147">
              <title>Introduction</title>
              <p>Approximately 1 in 10 US residents have type 2 diabetes (T2D).<sup><xref rid="zoi231147r1" ref-type="bibr">1</xref></sup> If current trends continue, 1 in 3 US adults will have T2D by 2050.<sup><xref rid="zoi231147r1" ref-type="bibr">1</xref></sup> Innovative lifestyle strategies to treat T2D are critically needed. Calorie restriction (CR) is generally encouraged as the first line of therapy to help people with T2D achieve their weight management goals and glycemic targets.<sup><xref rid="zoi231147r2" ref-type="bibr">2</xref></sup> However, many patients find it difficult to adhere to CR because calorie intake must be vigilantly monitored every day. Another approach that limits the timing of food intake instead of the number of calories consumed has recently been popularized. This diet is termed <italic>time-restricted eating</italic> (TRE) and involves confining daily food intake to 6 to 10 hours and fasting for the remaining hours. Evidence shows that limiting the eating window to 6 to 10 hours within a 24-hour period naturally reduces energy intake by 200 to 500 kcal/d.<sup><xref rid="zoi231147r3" ref-type="bibr">3</xref>,<xref rid="zoi231147r4" ref-type="bibr">4</xref>,<xref rid="zoi231147r5" ref-type="bibr">5</xref></sup> Moreover, since TRE allows individuals to self-select foods and eat freely during a large part of the day, adherence remains high for up to 12 months.<sup><xref rid="zoi231147r6" ref-type="bibr">6</xref></sup> Therefore, TRE may be an attractive alternative to CR for weight loss in patients with T2D.</p>
              <p>Only 2 TRE trials<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref>,<xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> to date have been conducted in adults with T2D. The preliminary findings of these trials show that TRE reduced body weight by 1% to 4%, lowered hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) levels by 1.5%, and increased time spent in the euglycemic range compared with controls.<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref>,<xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> However, these trials were limited by short duration (3-12 weeks) and lack of comparison with standard care (ie, daily CR).</p>
              <p>Accordingly, we conducted a 6-month, randomized clinical trial comparing the effects of 8-hour TRE (eating all food between 12:00 <sc>pm</sc> and 8:00 <sc>pm</sc>, without calorie counting) with CR (25% restriction daily) and a control condition on body weight and glycemic control in a group of adults with T2D and obesity. We hypothesized that the TRE group would achieve greater weight loss and larger reductions in HbA<sub>1c</sub> levels, compared with a CR group and a control group.</p>
            </sec>
            <sec id="H1-2-ZOI231147">
              <title>Methods</title>
              <p>The protocol for this randomized clinical trial was approved by the Office for the Protection of Research Subjects at the University of Illinois Chicago, and written informed consent was obtained from all participants. The full trial protocol and statistical analysis plan are provided in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 1</xref>. This study followed the Consolidated Standards of Reporting Trials (<ext-link xlink:href="https://www.equator-network.org/reporting-guidelines/consort/" ext-link-type="uri">CONSORT</ext-link>) reporting guidelines.</p>
              <sec id="H2-1-ZOI231147">
                <title>Trial Participants</title>
                <p>The trial was a 6-month, single-center, randomized clinical trial conducted at the University of Illinois Chicago between January 25, 2022, and April 1, 2023 (eFigure 1 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>). Inclusion criteria were as follows: previous diagnosis of T2D, HbA<sub>1c</sub> levels between 6.5% and 11.0% (to convert to proportion of total hemoglobin, multiply by 0.01), 18 to 80 years of age, and body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) between 30 and 50. Exclusion criteria consisted of unstable weight for 3 months prior to the beginning of the study (&gt;4% weight loss or gain), history of eating disorders, eating within less than a 10-hour window at baseline, nightshift work, pregnant or trying to become pregnant, and current smoking. Self-reported race and ethnicity data (including Asian, Hispanic White, non-Hispanic Black, and non-Hispanic White) were collected given that Hispanic and non-Hispanic Black adults have a high prevalence of T2D in the US.</p>
              </sec>
              <sec id="H2-2-ZOI231147">
                <title>Randomization and Blinding</title>
                <p>Participants were randomized in a 1:1:1 ratio to a TRE, CR, or control group. Randomization was performed by a stratified random sampling procedure by sex, age (18-49 and 50-80 years), BMI (30-39 and 40-50), and HbA<sub>1c</sub> level (6.50%-8.75% and 8.76%-11.00%). Participants were not blinded.</p>
              </sec>
              <sec id="H2-3-ZOI231147">
                <title>Intervention Groups</title>
                <p>Participants in the TRE group ate ad libitum between 12:00 and 8:00 <sc>pm</sc> daily and fasted from 8:00 <sc>pm</sc> to 12:00 <sc>pm</sc> the following day<sc>.</sc> During the 8-hour eating window, participants were not required to monitor caloric intake, and there were no restrictions on types or quantities of food consumed. During the 16-hour fasting window, participants were encouraged to drink plenty of water and were permitted to consume energy-free drinks. Participants self-monitored adherence to the eating window using a log in which they recorded the times that they started and stopped eating each day.</p>
                <p>Participants in the CR group were instructed to reduce their energy intake by 25% of their baseline energy needs every day. Total energy expenditure was calculated using the Mifflin equation.<sup><xref rid="zoi231147r9" ref-type="bibr">9</xref></sup> Participants met with a study dietitian (V.P.) at the beginning of the trial to develop individualized weight loss meal plans and self-monitored adherence to their calorie target by logging food intake into an app every day.</p>
                <p>Control participants were instructed to maintain their weight and usual eating and exercise habits. Control participants visited the research center at the same frequency as the intervention participants to provide outcome measurements.</p>
                <p>Participants in the TRE, CR, and control groups met with the study dietitian weekly from baseline to month 3 (by telephone or Zoom) and then biweekly thereafter. Body weight, adherence, medication changes, and adverse events were recorded during these calls. Participants in the TRE and CR groups were also taught how to make general healthy food choices that conform to American Diabetes Association nutrition guidelines.<sup><xref rid="zoi231147r2" ref-type="bibr">2</xref></sup> All participants were instructed not to change their physical activity habits throughout the trial.</p>
              </sec>
              <sec id="H2-4-ZOI231147">
                <title>Medication Management</title>
                <p>The medication management protocol was developed based on the literature.<sup><xref rid="zoi231147r10" ref-type="bibr">10</xref>,<xref rid="zoi231147r11" ref-type="bibr">11</xref></sup> If the participant’s baseline HbA<sub>1c</sub> level was below 7.0%, sulfonylureas were discontinued, the dose of short-acting insulin was reduced by 50%, and the dose of long-acting remained unchanged. If the participant’s baseline HbA<sub>1c</sub> level was greater than 7.0% but below 8.5%, the dose of sulfonylureas was reduced by 50%, the dose of short-acting insulin was reduced by 10%, and the dose of long-acting insulin remained unchanged. If the participant’s baseline HbA<sub>1c</sub> level was greater than 8.5%, doses of sulfonylurea, short-acting insulin, and long-acting insulin remained unchanged. No medication adjustments were made for controls.</p>
              </sec>
              <sec id="H2-5-ZOI231147">
                <title>Blood Glucose Level Monitoring</title>
                <p>All participants wore a continuous glucose monitor (CGM [Dexcom G7; DexCom, Inc]) for 10 days at baseline, month 3, and month 6. The CGM data were used to detect hypoglycemic (glucose level &lt;70 mg/dL [to convert to mmol/L, multiply by 0.0555]) or hyperglycemic (glucose level &gt;180 mg/dL) events. When participants were not wearing the CGM, they tested their blood glucose levels daily using a lancing device and glucose monitor.</p>
              </sec>
              <sec id="H2-6-ZOI231147">
                <title>Outcome Measures</title>
                <p>The primary outcome of the study was percentage change in body weight among the TRE, CR, and control groups by month 6. Secondary outcomes included changes in HbA<sub>1c</sub> levels, time in euglycemic range (glucose levels 70-180 mg/dL), mean glucose level (measured by CGM), medication effect score,<sup><xref rid="zoi231147r12" ref-type="bibr">12</xref></sup> body composition (measured by dual-energy x-ray absorptiometry), blood pressure and heart rate, plasma lipid levels, dietary intake (measured by the ASA-24 [automated self-administered 24-hour] dietary assessment tool<sup><xref rid="zoi231147r13" ref-type="bibr">13</xref></sup>), dietary adherence, physical activity (steps per day), and weekly adverse events among the TRE, CR, and control groups by month 6. Analytical methods are detailed in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 1</xref>. Reporting of serious adverse events followed requirements mandated by the University of Illinois Office for Protection of Research Subjects (<xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 1</xref>).</p>
              </sec>
              <sec id="H2-7-ZOI231147">
                <title>Statistical Analysis</title>
                <p>For the sample size calculation, we estimated that TRE and CR groups would reduce body weight by 7% and 3%, respectively, by month 6 compared with controls (estimated no change in body weight). We calculated that 21 participants per group would provide 80% power to detect a significant difference in body weight among the TRE, CR, and control groups by month 6, using an overall <italic>F</italic> test from a 1-way analysis of variance with α = .05, effect size of 0.4096, and a common SD of 7%. We anticipated a dropout rate of 15%.<sup><xref rid="zoi231147r4" ref-type="bibr">4</xref></sup> Thus, we aimed to recruit 75 participants (25 per group), assuming that 63 participants (21 per group) would complete the trial.</p>
                <p>Data are shown as mean (95% CI) unless otherwise noted. A Bonferroni-adjusted 2-tailed <italic>P</italic> &lt; .017 was considered statistically significant for pairwise group comparisons of percentage change in body weight. <italic>P</italic> values generated from analyses of secondary outcomes were not adjusted for multiplicity and are considered descriptive. We conducted an intention-to-treat analysis, which included data from all 75 participants who underwent randomization. Results are reported by intention-to-treat analysis unless indicated otherwise.</p>
                <p>A linear mixed model was used to assess time, group, and time × group effects for each outcome. In each model, time and group effects (and their interaction) were estimated without imposing a linear time trend. In models for body weight, which was measured at 7 time points (baseline and each of 6 months of follow-up), time was modeled with cubic splines. In models of all other outcome variables, which were measured at 2 time points (baseline and month 6), time was modeled as a categorical variable. All models were adjusted for baseline use of sodium-glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists to account for empirical baseline differences in medication use between treatment groups.</p>
                <p>For each outcome variable, linear modeling assumptions were assessed with residual diagnostics. To account for the potential of nonuniform variances (heteroskedasticity) between treatment groups due to random chance, all CIs and <italic>P</italic> values from linear mixed models were calculated using robust variance estimators (sandwich estimators).<sup><xref rid="zoi231147r14" ref-type="bibr">14</xref>,<xref rid="zoi231147r15" ref-type="bibr">15</xref>,<xref rid="zoi231147r16" ref-type="bibr">16</xref></sup> Intraclass correlation coefficients from each linear mixed effect were also calculated. To assess the effect of loss to follow-up on study findings, we conducted a sensitivity analysis using multiple imputation. Multiple imputation can incorporate observed data not otherwise accounted for in the model (eg, using baseline insulin levels to impute missing time in euglycemic range) to estimate multiple values for each missing data point and account for sampling variability. Missing follow-up data were imputed under the assumption that systematic differences between missing and observed outcomes can be explained by baseline values of the outcome as well as baseline values of height and waist circumference (and medication effect score and HbA<sub>1c</sub> level for glycemic outcomes), and all previous time points of weight. All analyses were performed using R software, version 4.3.1 (R Project for Statistical Computing).</p>
              </sec>
            </sec>
            <sec id="H1-3-ZOI231147">
              <title>Results</title>
              <sec id="H2-8-ZOI231147">
                <title>Trial Participants</title>
                <p>We screened 127 people and enrolled 75 participants (<xref rid="zoi231147f1" ref-type="fig">Figure 1</xref>). Participants had a mean (SD) age of 55 (12) years, mean (SD) BMI of 39 (7), and mean (SD) HbA<sub>1c</sub> level of 8.1% (1.6%). Fifty-three participants (71%) were women and 22 (29%) were men. One participant (1%) was Asian, 30 (40%) were Hispanic White, 40 (53%) were non-Hispanic Black, and 4 (5%) were non-Hispanic White (<xref rid="zoi231147t1" ref-type="table">Table 1</xref>). The attrition rate (ie, participants lost to follow-up) was 2 (8%) in the TRE group, 3 (12%) in the CR group, and 1 (4%) in the control group. The reasons for participant attrition included personal reasons, inability to contact, not wanting to be in the control group, and motor vehicle crash.</p>
                <fig position="float" id="zoi231147f1" fig-type="figure">
                  <label>Figure 1. </label>
                  <caption>
                    <title>Study Flowchart </title>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2339337-g001" position="float"/>
                </fig>
                <table-wrap position="float" id="zoi231147t1">
                  <label>Table 1. </label>
                  <caption>
                    <title>Baseline Characteristics of the Study Participants<xref rid="zoi231147t1n1" ref-type="table-fn"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="26.48%" span="1"/>
                    <col width="11.77%" span="1"/>
                    <col width="12.55%" span="1"/>
                    <col width="9.98%" span="1"/>
                    <col width="13.92%" span="1"/>
                    <col width="13.77%" span="1"/>
                    <col width="11.53%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Characteristic</th>
                        <th colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Participant group</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Study completion</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">TRE (n = 25)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">CR (n = 25)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Control (n = 25)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">All (N = 75)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Completed (n = 69)</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Dropped out (n = 6)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age, y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">55 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">54 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">55 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sex, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Women</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18 (72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17 (68)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18 (72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">53 (71)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">51 (74)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (33)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Men</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (32)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">22 (29)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18 (26)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (67)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Race and ethnicity, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Asian</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (17)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hispanic White</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 (40)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">11 (44)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">30 (40)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">27 (39)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (50)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Non-Hispanic Black</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (48)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (56)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (56)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (53)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">38 (55)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (33)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Non-Hispanic White</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">T2D duration, y</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Diabetes medications, No. (%)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Oral hypoglycemic agents</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Metformin</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">21 (84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (76)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">21 (84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">61 (81)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">57 (83)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (67)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> DPP-4 inhibitors</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 </td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> SGLT-2 inhibitors</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (17)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> GLP-1 receptor agonists</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 (32)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5 (20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6 (24)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (25)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18 (26)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (17)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sulfonylureas</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7 (28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">11 (15)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (33)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Insulin</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4 (16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">9 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">26 (35)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">25 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (17)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Medication effect score<xref rid="zoi231147t1n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Oral hypoglycemic agents</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.3 (0.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.0 (0.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.3 (0.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.2 (0.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.2 (0.8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.2 (1.1)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Insulin</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.5 (0.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.2 (0.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.3 (0.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4 (0.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.4 (0.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.2 (0.6)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Body weight, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">105 (25)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">104 (17)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">107 (22)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">105 (21)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">105 (22)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">108 (16)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Height, cm</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">165 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">166 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">165 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">165 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">165 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">171 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">BMI</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">39 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">38 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">39 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">39 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">39 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">HbA<sub>1c</sub> level, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.3 (2.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.1 (1.5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7.9 (1.3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.1 (1.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.0 (1.6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8.6 (1.7)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Time in euglycemic range, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">63 (30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60 (30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">62 (32)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">62 (30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">64 (30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">37 (15)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Glucose level, mg/dL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">180 (47)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">183 (59)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">177 (58)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">180 (54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">178 (56)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">203 (20)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Body composition</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Fat mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">43 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">49 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">47 (14)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">46 (9)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Lean mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">54 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">52 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">53 (10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">53 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">52 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56 (20)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Visceral fat mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.9 (0.7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.5 (1.0)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.2 (0.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.2 (0.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.2 (0.9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.4 (1.3)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Waist circumference, cm</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">117 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">120 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">121 (15)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">120 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">120 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">118 (10)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Blood pressure, mm Hg </td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> SBP</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">135 (17)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">137 (17)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">131 (20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">134 (18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">134 (18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">135 (19)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> DBP</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">85 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">87 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">85 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">86 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">85 (11)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">90 (15)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Heart rate, bpm</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">78 (14)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">80 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">79 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">78 (13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">85 (14)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Plasma lipid levels, mg/dL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">164 (44)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">171 (43)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">163 (39)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">166 (42)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">165 (43)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">174 (27)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> LDL cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">90 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">92 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">94 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">92 (36)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">92 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">94 (24)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> HDL cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48 (14)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">47 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">48 (12)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42 (6)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Triglycerides</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">130 (58)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">144 (64)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">121 (37)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">132 (55)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">127 (50)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">189 (75)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); bpm, beats per minute; CR, calorie restriction; DBP, diastolic blood pressure; DPP-4, dipeptidyl peptidase 4; GLP-1, glucagonlike peptide-1; HbA<sub>1c</sub>, hemoglobin A<sub>1c</sub>; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; SGLT-2, sodium-glucose transport protein 2; T2D, type 2 diabetes; TRE, time-restricted eating.</p>
                    <p>SI conversion factors: To convert cholesterol to mmol/L, multiply by 0.0258; glucose to mmol/L, multiply by 0.0555; HbA<sub>1c</sub> to proportion of total hemoglobin, multiply by 0.01; triglycerides to mmol/L, multiply by 0.0113.</p>
                    <fn id="zoi231147t1n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Unless otherwise indicated, data are expressed as mean (SD).</p>
                    </fn>
                    <fn id="zoi231147t1n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Calculated as (actual drug dose/maximum drug dose) × drug mean adjustment factor. A higher score corresponded to a higher dose of diabetes medication, and a reduction corresponded to a reduction in diabetes medication.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-9-ZOI231147">
                <title>Weight Loss and Body Composition</title>
                <p>By month 6, mean body weight significantly decreased in the TRE group (−3.56% [95% CI, −5.92% to −1.20%]; <italic>P</italic> = .004) but not the CR group (−1.78% [95% CI, −3.67% to 0.11%]; <italic>P</italic> = .06), relative to controls (<xref rid="zoi231147f2" ref-type="fig">Figure 2</xref>A and <xref rid="zoi231147t2" ref-type="table">Table 2</xref>). Fat mass decreased in the TRE group by month 6 (−2.49 [95% CI, −4.41 to −0.58] kg) but not the CR group (−1.65 [95% CI, −3.33 to 0.04] kg), relative to controls (<xref rid="zoi231147t2" ref-type="table">Table 2</xref>). Both TRE and CR led to reductions in waist circumference by month 6, but not lean mass or visceral fat mass, compared with controls. Relative to controls, BMI decreased in the TRE group by month 6, but not the CR group.</p>
                <fig position="float" id="zoi231147f2" fig-type="figure">
                  <label>Figure 2. </label>
                  <caption>
                    <title>Change in Body Composition and Glycemic Control in the Study Groups </title>
                    <p>Data were included for 75 participants; means were estimated using an intention-to-treat analysis using a linear mixed model. Error bars indicate 95% CIs for each parameter from baseline by diet group. CR indicates calorie restriction; TRE, time-restricted eating.</p>
                  </caption>
                  <graphic xlink:href="jamanetwopen-e2339337-g002" position="float"/>
                </fig>
                <table-wrap position="float" id="zoi231147t2">
                  <?xpp landscape?>
                  <label>Table 2. </label>
                  <caption>
                    <title>Body Weight, Glycemic Control, and Cardiometabolic Risk Factors<xref rid="zoi231147t2n1" ref-type="table-fn"><sup>a</sup></xref></title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="12.81%" span="1"/>
                    <col width="5.2%" span="1"/>
                    <col width="5.6%" span="1"/>
                    <col width="12.61%" span="1"/>
                    <col width="12.55%" span="1"/>
                    <col width="12.6%" span="1"/>
                    <col width="12.55%" span="1"/>
                    <col width="13.05%" span="1"/>
                    <col width="13.03%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Variable</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">No. of participants</th>
                        <th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Participant group, mean change from baseline (95% CI)</th>
                        <th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Mean difference between groups (95% CI)</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Baseline</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">6 mo</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">TRE</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">CR</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Control</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">TRE vs CR</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">TRE vs control</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">CR vs control</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Weight</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Body weight, % lost</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−4.28 (−6.26 to −2.31)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.50 (−3.83 to −1.18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.72 (−2.14 to 0.69)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.78 (−4.09 to 0.53)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.56 (−5.92 to −1.20)<xref rid="zoi231147t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.78 (−3.67 to 0.11)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Body weight, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−4.52 (−6.73 to −2.30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.63 (−3.99 to −1.27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.07 (−2.70 to 0.57)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.89 (−4.42 to 0.64)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.45 (−6.13 to −0.77)<xref rid="zoi231147t2n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.56 (−3.63 to 0.51)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Glycemic control</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> HbA<sub>1c</sub> level, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">72</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">66</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.72 (−1.25 to −0.18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.75 (−1.20 to −0.30)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.19 (−0.30 to 0.68)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.04 (−0.64 to 0.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.91 (−1.61 to −0.20)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">-0.94 (−1.59 to −0.30)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Time in euglycemic range, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4.78 (−3.52 to 13.08)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10.65 (2.65 to 18.65)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−7.81 (−24.90 to 9.27)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−5.87 (−17.03 to 5.28)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12.59 (−5.70 to 30.89)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18.46 (0.31 to 36.62)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mean glucose level, mg/dL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">56</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−11.02 (−24.85 to 2.82)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−17.03 (−30.49 to −3.58)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">31.51 (−4.54 to 67.56)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6.02 (−12.67 to 24.70)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−42.53 (−79.73 to −5.33)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−48.55 (−85.55 to −11.54)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Medication effect score</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> OHA</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">69</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.12 (−0.26 to 0.01)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.04 (−0.15 to 0.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.03 (−0.15 to 0.21)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.16 (−0.38 to 0.06)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.15 (−0.37 to 0.07)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.01 (−0.25 to 0.26)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Insulin</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">69</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.02 (−0.10 to 0.07)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.02 (−0.05 to 0.01)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.00 (0.00 to 0.00)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.01 (−0.08 to 0.09)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.02 (−0.10 to 0.07)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.02 (−0.05 to 0.01)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Body composition</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Fat mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">65</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.77 (−4.36 to −1.18)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.92 (−3.20 to −0.65)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.28 (−1.46 to 0.90)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.85 (−2.82 to 1.13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.49 (−4.41 to −0.58)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.65 (−3.33 to 0.04)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Lean mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">65</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.97 (−2.04 to 0.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.46 (−1.15 to 0.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.59 (−1.49 to 0.32)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.51 (−1.74 to 0.72)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.38 (−1.74 to 0.98)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.13 (−0.98 to 1.23)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Visceral fat mass, kg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">70</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">64</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.16 (−0.36 to 0.05)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.18 (−0.32 to −0.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.07 (−0.18 to 0.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.02 (−0.21 to 0.26)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.09 (−0.31 to 0.13)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.11 (−0.28 to 0.06)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Waist circumference, cm</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">74</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">67</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.92 (−5.93 to −1.91)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.97 (−6.03 to −1.92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.48 (−1.66 to 0.71)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.05 (−2.74 to 2.84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.44 (−5.71 to −1.18)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.50 (−5.80 to −1.20)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> BMI</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">68</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.78 (−2.63 to −0.94)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.89 (−1.36 to −0.41)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.37 (−0.95 to 0.22)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.90 (−1.83 to 0.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.41 (−2.41 to −0.42)<xref rid="zoi231147t2n3" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.52 (−1.25 to 0.21)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Blood pressure, mm Hg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> SBP</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">65</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−4.45 (−9.98 to 1.07)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−3.91 (−9.33 to 1.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.52 (−4.45 to 7.49)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.55 (−8.05 to 6.96)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−5.98 (−13.87 to 1.92)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−5.43 (−13.25 to 2.39)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> DBP</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">65</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.88 (−6.92 to 1.16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.47 (−3.86 to 0.93)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.06 (−3.22 to 3.34)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.41 (−5.97 to 3.14)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.94 (−7.98 to 2.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.52 (−5.46 to 2.41)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Heart rate, bpm</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">75</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">65</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−2.48 (−6.79 to 1.84)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.77 (−6.03 to 2.49)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.84 (−6.44, to 4.75)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.71 (−6.61 to 5.19)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.63 (−8.51 to 5.24)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.93 (−7.77 to 5.91)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Plasma lipid levels, mg/dL</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.18 (−10.55 to 10.20)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−8.12 (−22.86 to 6.63)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.88 (−15.67 to 11.90)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">7.94 (−9.47 to 25.35)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.71 (−14.97 to 18.38)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−6.23 (−25.76 to 13.30)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> LDL cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.23 (−9.56 to 9.10)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−4.57 (−16.19 to 7.04)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−4.86 (−16.76 to 7.05)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4.34 (−10.04 to 18.73)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">4.63 (−9.99 to 19.24)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0.28 (−15.81 to 16.38)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> HDL cholesterol</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.20 (0.88 to 5.52)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−0.23 (−3.68 to 3.23)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1.02 (−1.57 to 3.62)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.43 (−0.60 to 7.47)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2.18 (−1.19 to 5.54)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−1.25 (−5.44 to 2.93)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Triglycerides</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">71</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">60</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−15.43 (−37.92 to 7.06)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−9.53 (−25.14 to 6.08)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3.70 (−13.32 to 20.73)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−5.90 (−32.3 to 20.59)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−19.13 (−46.42 to 8.16)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">−13.23 (−35.62 to 9.15)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CR, calorie restriction; DBP, diastolic blood pressure; HbA<sub>1c</sub>, hemoglobin A<sub>1c</sub>; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OHA, oral hypoglycemic agent; SBP, systolic blood pressure; TRE, time-restricted eating.</p>
                    <p>SI conversion factors: To convert cholesterol to mmol/L, multiply by 0.0258; glucose to mmol/L, multiply by 0.0555; HbA<sub>1c</sub> to proportion of total hemoglobin, multiply by 0.01; triglycerides to mmol/L, multiply by 0.0113.</p>
                    <fn id="zoi231147t2n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Means were estimated using an intention-to-treat analysis using a linear mixed model with 95% CIs for each parameter from baseline by diet group.</p>
                    </fn>
                    <fn id="zoi231147t2n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Indicates statistical significance using Bonferroni-adjusted 2-tailed <italic>P</italic> &lt; .017.</p>
                    </fn>
                    <fn id="zoi231147t2n3">
                      <label>
                        <sup>c</sup>
                      </label>
                      <p>Indicates statistical significance using <italic>P</italic> &lt; .05.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-10-ZOI231147">
                <title>Glycemic Control and Medication Effect Score</title>
                <p>By month 6, mean HbA<sub>1c</sub> levels were reduced in the TRE group (−0.91% [95% CI, −1.61% to −0.20%]) and CR group (−0.94% [95% CI, −1.59% to −0.30%]), relative to controls, with no differences between the TRE and CR group (0.04% [95% CI, −0.64% to 0.72%]) (<xref rid="zoi231147f2" ref-type="fig">Figure 2</xref>B and <xref rid="zoi231147t2" ref-type="table">Table 2</xref>). Mean glucose levels decreased in the TRE group (−42.53 [95% CI, −79.73 to −5.33] mg/dL) and CR group (−48.55 [95% CI, −85.55 to −11.54] mg/dL), relative to controls, with no differences between the TRE and CR groups (6.02 [95% CI, −12.67 to 24.70] mg/dL) (<xref rid="zoi231147f2" ref-type="fig">Figure 2</xref>C and <xref rid="zoi231147t2" ref-type="table">Table 2</xref>). Time in the euglycemic range and medication effect scores were not associated with treatment group in any pairwise comparisons at month 6 (<xref rid="zoi231147t2" ref-type="table">Table 2</xref>). Medication use at baseline and month 6 is reported in eTable 1 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p>
              </sec>
              <sec id="H2-11-ZOI231147">
                <title>Sensitivity Analysis Using Multiple Imputation</title>
                <p>Conclusions for body weight and HbA<sub>1c</sub> level did not change from the primary analyses to the sensitivity analyses (eTable 2 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>), demonstrating that the results are robust to misspecification of the missingness mechanism. However, sensitivity analyses differed from primary analyses for some secondary outcomes: fat mass decreased in both the TRE and the CR groups by month 6 relative to controls (rather than in the TRE group alone), and mean glucose levels decreased in the CR group only. Conclusions did not change between the primary analysis and sensitivity analysis for any other secondary outcome.</p>
              </sec>
              <sec id="H2-12-ZOI231147">
                <title>Plasma Lipid Levels and Blood Pressure</title>
                <p>Changes in blood pressure, heart rate, total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride concentrations were observed. However, these changes were not associated with treatment group in any pairwise comparisons at month 6 (<xref rid="zoi231147t2" ref-type="table">Table 2</xref>).</p>
              </sec>
              <sec id="H2-13-ZOI231147">
                <title>Adherence and Energy Intake</title>
                <p> The mean (SD) caloric deficit was −313 (509) kcal/d for the TRE group, −197 (426) kcal/d for the CR group, and −16 (439) kcal/d for the control group over 6 months. Differences in dietary intake among groups are given in <xref rid="zoi231147t3" ref-type="table">Table 3</xref>. The TRE group reported being adherent with their eating window a mean (SD) of 6.1 (0.8) days per week (87% of days) over 6 months (eFigure 2 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>). In the CR group, 17 participants (68%) reported being adherent with their prescribed calorie goals during the 6-month trial (eFigure 2 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>). Participants in the TRE group reported finding their diet intervention easier to adhere to compared with CR group participants (eFigure 3 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>).</p>
                <table-wrap position="float" id="zoi231147t3">
                  <label>Table 3. </label>
                  <caption>
                    <title>Dietary Intake and Physical Activity</title>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col width="23.76%" span="1"/>
                    <col width="13.38%" span="1"/>
                    <col width="12.28%" span="1"/>
                    <col width="13.38%" span="1"/>
                    <col width="11.9%" span="1"/>
                    <col width="13.38%" span="1"/>
                    <col width="11.92%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="3" valign="top" align="left" scope="col" colspan="1">Variable</th>
                        <th colspan="6" valign="top" align="left" scope="colgroup" rowspan="1">Participant group, mean (SD)<xref rid="zoi231147t3n1" ref-type="table-fn"><sup>a</sup></xref></th>
                      </tr>
                      <tr>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">TRE</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">CR</th>
                        <th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Control</th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Baseline</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">6 mo</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Baseline</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">6 mo</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">Baseline</th>
                        <th valign="top" align="left" scope="col" rowspan="1" colspan="1">6 mo</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Daily eating window</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">11 h 55 min (1 h 37 min)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">8 h 3 min (1 h 54 min)<xref rid="zoi231147t3n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 h 29 min (1 h 36 min)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 h 23 min (1 h 35 min)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 h 23 min (1 h 26 min)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">10 h 21 min (1 h 14 min)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Energy intake, kcal/d</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1978 (582)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1665 (468)<xref rid="zoi231147t3n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1707 (319)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1510 (358)<xref rid="zoi231147t3n2" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1834 (354)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1818 (14)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="col" rowspan="1" colspan="1">Dietary intake</td>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                        <td valign="top" align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Protein, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">18 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">17 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">19 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Carbohydrates, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42 (8)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (9)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total sugar, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (7)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Fat, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">42 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41 (9)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">40 (5)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">41 (7)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Saturated fat, %</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">12 (2)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cholesterol, mg</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">363 (146)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">302 (97)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">329 (149)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">306 (111)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">352 (126)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">308 (142)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Fiber, g</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">16 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">14 (6)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">15 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">13 (4)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sodium, mg/d</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3602 (1233)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3402 (790)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3259 (866)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2927 (614)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3311 (1095)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">3126 (1291)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Caffeine, mg/d</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">91 (66)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">93 (107)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">90 (78)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">81 (93)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">89 (99)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">96 (99)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Alcohol, g/d</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (4)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">2 (3)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">1 (2)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 (1)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">0 (1)</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Physical activity, steps/d</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5568 (2908)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6049 (2625)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6142 (4885)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6025 (4701)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">6051 (2623)</td>
                        <td valign="top" align="left" rowspan="1" colspan="1">5512 (2545)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <p>Abbreviations: CR, calorie restriction; TRE, time-restricted eating.</p>
                    <fn id="zoi231147t3n1">
                      <label>
                        <sup>a</sup>
                      </label>
                      <p>Only observed values are included. A total of 20 of 25 participants in the TRE group, 20 of 25 in the CR group, and 19 of 25 in the control group returned all food recalls.</p>
                    </fn>
                    <fn id="zoi231147t3n2">
                      <label>
                        <sup>b</sup>
                      </label>
                      <p>Significantly different from baseline (<italic>P</italic> &lt; .05).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="H2-14-ZOI231147">
                <title>Daily Eating Window, Diet Quality, and Physical Activity</title>
                <p>The daily eating window in the TRE group decreased from baseline to month 6 but remained unchanged in the CR and control groups (<xref rid="zoi231147t3" ref-type="table">Table 3</xref>). Dietary intake and physical activity did not differ over time or between groups (<xref rid="zoi231147t3" ref-type="table">Table 3</xref>).</p>
              </sec>
              <sec id="H2-15-ZOI231147">
                <title>Adverse Events</title>
                <p>No serious adverse events were reported. Occurrences of hypoglycemia and hyperglycemia did not differ between groups (eTable 3 in <xref rid="note-ZOI231147-1-s" ref-type="supplementary-material">Supplement 2</xref>).</p>
              </sec>
            </sec>
            <sec id="H1-4-ZOI231147">
              <title>Discussion</title>
              <p>Findings of this randomized clinical trial show that 8-hour TRE produced greater weight loss when compared with CR and a control condition. Despite the greater weight loss achieved by the TRE group, reductions in HbA<sub>1c</sub> levels were similar in the TRE and CR groups compared with the control group. Participants in the TRE group found it easier to adhere to their intervention and achieved greater overall energy restriction compared with the CR group. Medication effect score did not change in any group, and no serious adverse events were reported.</p>
              <p>Only 2 clinical trials<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref>,<xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> to date have examined how TRE affects body weight in patients with T2D. Che and colleagues<sup><xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> demonstrated that 12 weeks of 10-hour TRE (without calorie counting) reduced body weight by 3.5% compared with controls in 120 adults with obesity and T2D. Likewise, Andriessen et al<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref></sup> showed that 9-hour TRE produced 1.1% weight loss after 3 weeks compared with controls among 14 men and women with obesity and T2D. The weight loss produced by our 8-hour TRE intervention was slightly greater (4.3% from baseline) than that of previous reports,<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref>,<xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> but this was most likely due to the longer intervention period (6 months). In contrast, the weight loss by the CR group was not significant relative to the control or TRE group. This is surprising, as CR generally reduces body weight by 4% to 7% after 6 months in people with T2D.<sup><xref rid="zoi231147r17" ref-type="bibr">17</xref>,<xref rid="zoi231147r18" ref-type="bibr">18</xref>,<xref rid="zoi231147r19" ref-type="bibr">19</xref></sup> However, the participants in the CR group in our trial reported more difficulty with adhering to their intervention, relative to TRE. Since CR is commonly prescribed as a first-line intervention in T2D, it is likely that our participants had already tried calorie counting in the past, without success. Time-restricted eating may have served as a refreshing alternative to CR, in that it only required patients to count time instead of calories, which may have bolstered overall adherence and weight loss in the TRE group.</p>
              <p>Reductions in HbA<sub>1c</sub> levels were similar for participants in the TRE (−0.91%) and CR (−0.94%) groups, relative to controls. Our findings for HbA<sub>1c</sub> levels are comparable to other TRE trials in T2D<sup><xref rid="zoi231147r7" ref-type="bibr">7</xref>,<xref rid="zoi231147r8" ref-type="bibr">8</xref></sup> and the Look AHEAD (Action for Health in Diabetes) study, which implemented daily CR.<sup><xref rid="zoi231147r20" ref-type="bibr">20</xref></sup> The improvements in HbA<sub>1c</sub> levels by CR are somewhat unexpected, since only the TRE group lost weight relative to controls. However, both TRE and CR led to comparable reductions in waist circumference (a surrogate marker of visceral fat mass). Evidence suggests that visceral fat mass may be a stronger factor associated with changes in glycemic control than body weight alone.<sup><xref rid="zoi231147r21" ref-type="bibr">21</xref>,<xref rid="zoi231147r22" ref-type="bibr">22</xref></sup> Moreover, both the TRE and CR groups received individualized diabetes nutrition counseling, which has been shown significantly improve HbA<sub>1c</sub> levels.<sup><xref rid="zoi231147r23" ref-type="bibr">23</xref>,<xref rid="zoi231147r24" ref-type="bibr">24</xref></sup> These factors may explain why similar improvements in HbA<sub>1c</sub> levels were noted in the TRE and CR groups, even though only the TRE group lost weight relative to controls.</p>
              <p>Our findings also show that TRE is safe in patients who are using either diet alone or medications to control their T2D. However, for people using sulfonylureas and/or insulin, adopting a TRE regimen will require medication changes and regular monitoring, particularly in the initial stages of the diet.</p>
              <p>Hispanic and non-Hispanic Black adults are among the racial and ethnic groups with the highest prevalence of T2D in the US.<sup><xref rid="zoi231147r25" ref-type="bibr">25</xref></sup> Our results show that TRE is effective for weight loss and HbA<sub>1c</sub> level reductions in a sample population that was representative of these 2 groups. Time-restricted eating is an appealing approach to weight loss in that it can be adopted at no cost, allows patients to continue consuming familiar foods, and does not require complicated calorie counting. Since the literature on TRE is still quite limited,<sup><xref rid="zoi231147r26" ref-type="bibr">26</xref></sup> our trial may help to improve the health of groups with a high prevalence of T2D by filling in these critical knowledge gaps.</p>
              <sec id="H2-16-ZOI231147">
                <title>Limitations</title>
                <p>Our study has some limitations, which include the relatively short trial duration and the lack of blinding of participants. Moreover, a higher percentage of participants in the TRE group were using sodium-glucose transport protein 2 inhibitors and glucagonlike peptide-1 receptor agonists at baseline. These medications could have influenced our body weight findings,<sup><xref rid="zoi231147r27" ref-type="bibr">27</xref></sup> even though participants had stable weight before enrollment. To control for these confounding variables, we accounted for the use of these medications in the analyses of our primary and secondary outcomes. In addition, we relied on self-reported dietary intake. Since individuals with obesity tend to underreport energy consumption by 15% to 20%,<sup><xref rid="zoi231147r28" ref-type="bibr">28</xref></sup> it is likely that our estimates of energy intake are inaccurate. Last, TRE itself can be associated with greater self-monitoring and lower caloric intake, so although these effects were noted in the TRE group, these are expected as part of the intervention.</p>
              </sec>
            </sec>
            <sec id="H1-5-ZOI231147">
              <title>Conclusion</title>
              <p>This randomized clinical trial found that 8-hour TRE without calorie counting was an effective alternative diet strategy for weight loss and lowering of HbA<sub>1c</sub> levels compared with daily calorie counting in a sample of adults with T2D and obesity. These findings will need to be confirmed by larger RCTs with longer follow-up.</p>
            </sec>
          </body>
          <back>
            <ref-list id="REF-ZOI231147">
              <title>References</title>
              <ref id="zoi231147r1">
                <label>1</label>
                <mixed-citation publication-type="webpage"><person-group><collab>Centers for Disease Control and Prevention</collab></person-group>. Type 2 diabetes. Reviewed April 18, <year>2023</year>. Accessed April 18, 2023. <ext-link xlink:href="https://www.cdc.gov/diabetes/basics/type2.html" ext-link-type="uri">https://www.cdc.gov/diabetes/basics/type2.html</ext-link></mixed-citation>
              </ref>
              <ref id="zoi231147r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Evert</surname><given-names>AB</given-names></string-name>, <string-name><surname>Dennison</surname><given-names>M</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>CD</given-names></string-name>, <etal/></person-group>. <article-title>Nutrition therapy for adults with diabetes or prediabetes: a consensus report</article-title>. <source>Diabetes Care</source>. <year>2019</year>;<volume>42</volume>(<issue>5</issue>):<fpage>731</fpage>-<lpage>754</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dci19-0014</pub-id><?supplied-pmid 31000505?><pub-id pub-id-type="pmid">31000505</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wilkinson</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Manoogian</surname><given-names>ENC</given-names></string-name>, <string-name><surname>Zadourian</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome</article-title>. <source>Cell Metab</source>. <year>2020</year>;<volume>31</volume>(<issue>1</issue>):<fpage>92</fpage>-<lpage>104.e5</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2019.11.004</pub-id><?supplied-pmid 31813824?><pub-id pub-id-type="pmid">31813824</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cienfuegos</surname><given-names>S</given-names></string-name>, <string-name><surname>Gabel</surname><given-names>K</given-names></string-name>, <string-name><surname>Kalam</surname><given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity</article-title>. <source>Cell Metab</source>. <year>2020</year>;<volume>32</volume>(<issue>3</issue>):<fpage>366</fpage>-<lpage>378.e3</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmet.2020.06.018</pub-id><?supplied-pmid 32673591?><pub-id pub-id-type="pmid">32673591</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Gabel</surname><given-names>K</given-names></string-name>, <string-name><surname>Hoddy</surname><given-names>KK</given-names></string-name>, <string-name><surname>Haggerty</surname><given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: a pilot study</article-title>. <source>Nutr Healthy Aging</source>. <year>2018</year>;<volume>4</volume>(<issue>4</issue>):<fpage>345</fpage>-<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.3233/NHA-170036</pub-id><?supplied-pmid 29951594?><pub-id pub-id-type="pmid">29951594</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Liu</surname><given-names>D</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Huang</surname><given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Calorie restriction with or without time-restricted eating in weight loss</article-title>. <source>N Engl J Med</source>. <year>2022</year>;<volume>386</volume>(<issue>16</issue>):<fpage>1495</fpage>-<lpage>1504</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2114833</pub-id><?supplied-pmid 35443107?><pub-id pub-id-type="pmid">35443107</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Andriessen</surname><given-names>C</given-names></string-name>, <string-name><surname>Fealy</surname><given-names>CE</given-names></string-name>, <string-name><surname>Veelen</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial</article-title>. <source>Diabetologia</source>. <year>2022</year>;<volume>65</volume>(<issue>10</issue>):<fpage>1710</fpage>-<lpage>1720</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00125-022-05752-z</pub-id><?supplied-pmid 35871650?><pub-id pub-id-type="pmid">35871650</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Che</surname><given-names>T</given-names></string-name>, <string-name><surname>Yan</surname><given-names>C</given-names></string-name>, <string-name><surname>Tian</surname><given-names>D</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Liu</surname><given-names>X</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Z</given-names></string-name></person-group>. <article-title>Time-restricted feeding improves blood glucose and insulin sensitivity in overweight patients with type 2 diabetes: a randomised controlled trial</article-title>. <source>Nutr Metab (Lond)</source>. <year>2021</year>;<volume>18</volume>(<issue>1</issue>):<fpage>88</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12986-021-00613-9</pub-id><?supplied-pmid 34620199?><pub-id pub-id-type="pmid">34620199</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mifflin</surname><given-names>MD</given-names></string-name>, <string-name><surname>St Jeor</surname><given-names>ST</given-names></string-name>, <string-name><surname>Hill</surname><given-names>LA</given-names></string-name>, <string-name><surname>Scott</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Daugherty</surname><given-names>SA</given-names></string-name>, <string-name><surname>Koh</surname><given-names>YO</given-names></string-name></person-group>. <article-title>A new predictive equation for resting energy expenditure in healthy individuals</article-title>. <source>Am J Clin Nutr</source>. <year>1990</year>;<volume>51</volume>(<issue>2</issue>):<fpage>241</fpage>-<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ajcn/51.2.241</pub-id><?supplied-pmid 2305711?><pub-id pub-id-type="pmid">2305711</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Carter</surname><given-names>S</given-names></string-name>, <string-name><surname>Clifton</surname><given-names>PM</given-names></string-name>, <string-name><surname>Keogh</surname><given-names>JB</given-names></string-name></person-group>. <article-title>Effect of intermittent compared with continuous energy restricted diet on glycemic control in patients with type 2 diabetes: a randomized noninferiority trial</article-title>. <source>JAMA Netw Open</source>. <year>2018</year>;<volume>1</volume>(<issue>3</issue>):<elocation-id>e180756</elocation-id>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2018.0756</pub-id><?supplied-pmid 30646030?><pub-id pub-id-type="pmid">30646030</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Grajower</surname><given-names>MM</given-names></string-name>, <string-name><surname>Horne</surname><given-names>BD</given-names></string-name></person-group>. <article-title>Clinical management of intermittent fasting in patients with diabetes mellitus</article-title>. <source>Nutrients</source>. <year>2019</year>;<volume>11</volume>(<issue>4</issue>):<fpage>873</fpage>. doi:<pub-id pub-id-type="doi">10.3390/nu11040873</pub-id><?supplied-pmid 31003482?><pub-id pub-id-type="pmid">31003482</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mayer</surname><given-names>SB</given-names></string-name>, <string-name><surname>Jeffreys</surname><given-names>AS</given-names></string-name>, <string-name><surname>Olsen</surname><given-names>MK</given-names></string-name>, <string-name><surname>McDuffie</surname><given-names>JR</given-names></string-name>, <string-name><surname>Feinglos</surname><given-names>MN</given-names></string-name>, <string-name><surname>Yancy</surname><given-names>WS</given-names><suffix>Jr</suffix></string-name></person-group>. <article-title>Two diets with different haemoglobin A<sub>1c</sub> and antiglycaemic medication effects despite similar weight loss in type 2 diabetes</article-title>. <source>Diabetes Obes Metab</source>. <year>2014</year>;<volume>16</volume>(<issue>1</issue>):<fpage>90</fpage>-<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1111/dom.12191</pub-id><?supplied-pmid 23911112?><pub-id pub-id-type="pmid">23911112</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r13">
                <label>13</label>
                <mixed-citation publication-type="webpage"><person-group><collab>National Institutes of Health</collab></person-group>. Automated self-administered 24-hour (ASA24®) dietary assessment tool. Accessed April 18, 2023. <ext-link xlink:href="https://epi.grants.cancer.gov/asa24/" ext-link-type="uri">https://epi.grants.cancer.gov/asa24/</ext-link></mixed-citation>
              </ref>
              <ref id="zoi231147r14">
                <label>14</label>
                <mixed-citation publication-type="confproc"><person-group><string-name><surname>Huber</surname><given-names>PJ</given-names></string-name></person-group>. The behavior of maximum likelihood estimates under nonstandard conditions. In: Le Cam LM, Neyman J, eds. <italic>Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability</italic>. Univerisity of California Press; <year>1967</year>;5.1:221-233.</mixed-citation>
              </ref>
              <ref id="zoi231147r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Mansournia</surname><given-names>MA</given-names></string-name>, <string-name><surname>Nazemipour</surname><given-names>M</given-names></string-name>, <string-name><surname>Naimi</surname><given-names>AI</given-names></string-name>, <string-name><surname>Collins</surname><given-names>GS</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>MJ</given-names></string-name></person-group>. <article-title>Reflection on modern methods: demystifying robust standard errors for epidemiologists</article-title>. <source>Int J Epidemiol</source>. <year>2021</year>;<volume>50</volume>(<issue>1</issue>):<fpage>346</fpage>-<lpage>351</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ije/dyaa260</pub-id><?supplied-pmid 33351919?><pub-id pub-id-type="pmid">33351919</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>White</surname><given-names>H</given-names></string-name></person-group>. <article-title>A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity</article-title>. <source>Econometrica</source>. <year>1980</year>;<volume>48</volume>(<issue>4</issue>):<fpage>817</fpage>-<lpage>838</lpage>. doi:<pub-id pub-id-type="doi">10.2307/1912934</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Jayedi</surname><given-names>A</given-names></string-name>, <string-name><surname>Zeraattalab-Motlagh</surname><given-names>S</given-names></string-name>, <string-name><surname>Shahinfar</surname><given-names>H</given-names></string-name>, <string-name><surname>Gregg</surname><given-names>EW</given-names></string-name>, <string-name><surname>Shab-Bidar</surname><given-names>S</given-names></string-name></person-group>. <article-title>Effect of calorie restriction in comparison to usual diet or usual care on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Am J Clin Nutr</source>. <year>2023</year>;<volume>117</volume>(<issue>5</issue>):<fpage>870</fpage>-<lpage>882</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajcnut.2023.03.018</pub-id><?supplied-pmid 36972801?><pub-id pub-id-type="pmid">36972801</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Norris</surname><given-names>SL</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Avenell</surname><given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis</article-title>. <source>Am J Med</source>. <year>2004</year>;<volume>117</volume>(<issue>10</issue>):<fpage>762</fpage>-<lpage>774</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjmed.2004.05.024</pub-id><?supplied-pmid 15541326?><pub-id pub-id-type="pmid">15541326</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Yang</surname><given-names>J</given-names></string-name>, <string-name><surname>Xia</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name>, <etal/></person-group>. <article-title>Effect of lifestyle intervention on HbA<sub>1c</sub> levels in overweight and obese adults with type 2 diabetes across ethnicities: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2023</year>;<volume>199</volume>:<elocation-id>110662</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.diabres.2023.110662</pub-id><?supplied-pmid 37028602?><pub-id pub-id-type="pmid">37028602</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Pi-Sunyer</surname><given-names>X</given-names></string-name>, <string-name><surname>Blackburn</surname><given-names>G</given-names></string-name>, <string-name><surname>Brancati</surname><given-names>FL</given-names></string-name>, <etal/>; <collab>Look AHEAD Research Group</collab></person-group>. <article-title>Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>6</issue>):<fpage>1374</fpage>-<lpage>1383</lpage>. doi:<pub-id pub-id-type="doi">10.2337/dc07-0048</pub-id><?supplied-pmid 17363746?><pub-id pub-id-type="pmid">17363746</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Han</surname><given-names>TS</given-names></string-name>, <string-name><surname>Al-Gindan</surname><given-names>YY</given-names></string-name>, <string-name><surname>Govan</surname><given-names>L</given-names></string-name>, <string-name><surname>Hankey</surname><given-names>CR</given-names></string-name>, <string-name><surname>Lean</surname><given-names>MEJ</given-names></string-name></person-group>. <article-title>Associations of BMI, waist circumference, body fat, and skeletal muscle with type 2 diabetes in adults</article-title>. <source>Acta Diabetol</source>. <year>2019</year>;<volume>56</volume>(<issue>8</issue>):<fpage>947</fpage>-<lpage>954</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00592-019-01328-3</pub-id><?supplied-pmid 30927105?><pub-id pub-id-type="pmid">30927105</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Zhen</surname><given-names>J</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>G</given-names></string-name>, <etal/></person-group>. <article-title>Association of waist circumference with haemoglobin A<sub>1c</sub> and its optimal cutoff for identifying prediabetes and diabetes risk in the Chinese population</article-title>. <source>Intern Emerg Med</source>. <year>2022</year>;<volume>17</volume>(<issue>7</issue>):<fpage>2039</fpage>-<lpage>2044</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11739-022-03072-z</pub-id><?supplied-pmid 36002618?><pub-id pub-id-type="pmid">36002618</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group><collab>Diabetes Prevention Program Research Group</collab></person-group>. <article-title>Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2015</year>;<volume>3</volume>(<issue>11</issue>):<fpage>866</fpage>-<lpage>875</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-8587(15)00291-0</pub-id><?supplied-pmid 26377054?><pub-id pub-id-type="pmid">26377054</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Kim</surname><given-names>J</given-names></string-name>, <string-name><surname>Hur</surname><given-names>MH</given-names></string-name></person-group>. <article-title>The effects of dietary education interventions on individuals with type 2 diabetes: a systematic review and meta-analysis</article-title>. <source>Int J Environ Res Public Health</source>. <year>2021</year>;<volume>18</volume>(<issue>16</issue>):<fpage>8439</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph18168439</pub-id><?supplied-pmid 34444187?><pub-id pub-id-type="pmid">34444187</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Cheng</surname><given-names>YJ</given-names></string-name>, <string-name><surname>Kanaya</surname><given-names>AM</given-names></string-name>, <string-name><surname>Araneta</surname><given-names>MRG</given-names></string-name>, <etal/></person-group>. <article-title>Prevalence of diabetes by race and ethnicity in the United States, 2011-2016</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>322</volume>(<issue>24</issue>):<fpage>2389</fpage>-<lpage>2398</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2019.19365</pub-id><?supplied-pmid 31860047?><pub-id pub-id-type="pmid">31860047</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Turner</surname><given-names>BE</given-names></string-name>, <string-name><surname>Steinberg</surname><given-names>JR</given-names></string-name>, <string-name><surname>Weeks</surname><given-names>BT</given-names></string-name>, <string-name><surname>Rodriguez</surname><given-names>F</given-names></string-name>, <string-name><surname>Cullen</surname><given-names>MR</given-names></string-name></person-group>. <article-title>Race/ethnicity reporting and representation in US clinical trials: a cohort study</article-title>. <source>Lancet Reg Health Am</source>. <year>2022</year>;<volume>11</volume>:<elocation-id>100252</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.lana.2022.100252</pub-id><?supplied-pmid 35875251?><pub-id pub-id-type="pmid">35875251</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Wilding</surname><given-names>JPH</given-names></string-name>, <string-name><surname>Batterham</surname><given-names>RL</given-names></string-name>, <string-name><surname>Calanna</surname><given-names>S</given-names></string-name>, <etal/>; <collab>STEP 1 Study Group</collab></person-group>. <article-title>Once-weekly semaglutide in adults with overweight or obesity</article-title>. <source>N Engl J Med</source>. <year>2021</year>;<volume>384</volume>(<issue>11</issue>):<fpage>989</fpage>-<lpage>1002</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa2032183</pub-id><?supplied-pmid 33567185?><pub-id pub-id-type="pmid">33567185</pub-id></mixed-citation>
              </ref>
              <ref id="zoi231147r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group><string-name><surname>Schoeller</surname><given-names>DA</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>D</given-names></string-name>, <string-name><surname>Archer</surname><given-names>E</given-names></string-name>, <etal/></person-group>. <article-title>Self-report-based estimates of energy intake offer an inadequate basis for scientific conclusions</article-title>. <source>Am J Clin Nutr</source>. <year>2013</year>;<volume>97</volume>(<issue>6</issue>):<fpage>1413</fpage>-<lpage>1415</lpage>. doi:<pub-id pub-id-type="doi">10.3945/ajcn.113.062125</pub-id><?supplied-pmid 23689494?><pub-id pub-id-type="pmid">23689494</pub-id></mixed-citation>
              </ref>
            </ref-list>
            <notes notes-type="supplementary-material" id="note-ZOI231147-1">
              <supplementary-material id="note-ZOI231147-1-s" position="float" content-type="local-data">
                <label>Supplement 1.</label>
                <caption>
                  <p>
Trial Protocol
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2339337-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 2.</label>
                <caption>
                  <p><bold>eTable 1</bold>. Medication Use at Baseline and Month 6</p>
                  <p><bold>eTable 2</bold>. Multiple Imputation Sensitivity Analysis Results</p>
                  <p><bold>eTable 3</bold>. Adverse Events During the Intervention</p>
                  <p><bold>eFigure 1</bold>. Experimental Design</p>
                  <p><bold>eFigure 2.</bold> Adherence to the Diet Interventions</p>
                  <p><bold>eFigure 3</bold>. Difficulty in Adhering to the Time-Restricted Eating vs Calorie Restriction Intervention</p>
                </caption>
                <media xlink:href="jamanetwopen-e2339337-s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material position="float" content-type="local-data">
                <label>Supplement 3.</label>
                <caption>
                  <p>
Data Sharing Statement
</p>
                </caption>
                <media xlink:href="jamanetwopen-e2339337-s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </notes>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
